|
CRNKL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.27990975992998E-13 |
| Normal-vs-Stage2 |
1.00620000109686E-08 |
| Normal-vs-Stage3 |
4.06308320322069E-12 |
| Normal-vs-Stage4 |
2.77755596300722E-12 |
| Stage1-vs-Stage2 |
7.972200E-01 |
| Stage1-vs-Stage3 |
4.268200E-01 |
| Stage1-vs-Stage4 |
2.164400E-02 |
| Stage2-vs-Stage3 |
7.522600E-01 |
| Stage2-vs-Stage4 |
1.330580E-01 |
| Stage3-vs-Stage4 |
1.913970E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.77315972805081E-15 |
| Normal-vs-AfricanAmerican |
3.583600E-04 |
| Normal-vs-Asian |
4.77930028885964E-10 |
| Caucasian-vs-AfricanAmerican |
2.649200E-01 |
| Caucasian-vs-Asian |
7.095400E-01 |
| AfricanAmerican-vs-Asian |
2.010400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.89448498292222E-14 |
| Normal-vs-Female |
1.64523950019202E-12 |
| Male-vs-Female |
2.936000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.90909551792629E-11 |
| Normal-vs-Age(41-60Yrs) |
3.14193115968919E-14 |
| Normal-vs-Age(61-80Yrs) |
4.38193925589303E-12 |
| Normal-vs-Age(81-100Yrs) |
3.159500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.824210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.524000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.114000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.869800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.784000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.697800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.117850E-01 |
| Classical-VS-Follicular |
3.924600E-03 |
| Classical-VS-Other |
3.337200E-01 |
| Classical-VS-Normal |
2.92910140586855E-12 |
| Tall-VS-Follicular |
7.740400E-01 |
| Tall-VS-Other |
8.758400E-01 |
| Tall-VS-Normal |
2.75470002364386E-09 |
| Follicular-VS-Other |
9.930400E-01 |
| Follicular-VS-Normal |
3.5464964298626E-12 |
| Other-VS-Normal |
1.655440E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.05391259555654E-14 |
| Normal-vs-N1 |
4.16839895933663E-11 |
| N0-vs-N1 |
1.542780E-01 |
|
|
